Central catecholamine metabolism in vivo and the cognitive and motor deficits in Parkinson's disease

J. John Mann, Michael Stanley, Richard D. Kaplan, John Sweeney, Andreas Neophytides

Research output: Contribution to journalArticle

28 Scopus citations


Cerebrospinal fluid levels of homovanillic acid (HVA) in unmedicated patients with Parkinson's disease were 45% of levels in control subjects. Levels of 3- methoxy-4-hydroxyphenylglycol (MHPG) and platelet monoamine oxidase activity (MAO) did not differ. Within the Parkinson's disease group platelet MAO B activity correlated with HVA (an MAO B substrate) but not MHPG (an MAO A substrate). A mild global dementia was found that did not correlate with the more severe motor deficit. There was a negative correlation between the motor deficit and HVA levels but not with MHPG. Cognitive functioning correlated positively with platelet MAO, and the ratio of HVA to MHPG levels and negatively with MHPG alone. It is postulated that dopaminergic and noradrenergic activity or the functional balance between these systems may contribute to the observed cognitive dysfunction.

Original languageEnglish (US)
Pages (from-to)905-910
Number of pages6
JournalJournal of Neurology, Neurosurgery and psychiatry
Issue number10
StatePublished - Jan 1 1983


ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology
  • Psychiatry and Mental health

Cite this